Photobiomodulation Therapy for Multiple Painful Fixed Drug Eruptions: The First Case Report PBMT for Painful Fixed Drug Eruptions
Journal of Lasers in Medical Sciences,
Vol. 14 (2023),
29 January 2023
,
Page e4
Abstract
Introduction: Fixed drug eruption (FDE), is a very specific adverse drug reaction and one of the most common types of drug eruption generally resolves spontaneously within 7-10 days upon withdrawal of the causative agent; however, extensive and severe cases may also require systemic drug therapy. The present study aimed to report a case in which a broad spectrum of severe, painful lesions of FDE was managed with photobiomodulation therapy (PBMT).
Case Report: A 31-year-old Caucasian woman presented with many extremely painful mucocutaneous lesions of FDE which had arisen 8 days before, following a long period of hospitalization. The lesions were not responsive to either corticosteroids or analgesics within 5 days, and then seven daily sessions of PBMT were proposed. Pain alleviation was achieved on the 1st day of PBMT, and the lesions showed an advanced course of healing on the 3rd day. Within 7 days of PBMT, the lesions were almost completely repaired. In a 3-month follow-up period, no relapse of any FDE lesion was reported.
Conclusion: PBMT may be a promising strategy for the management of painful lesions of FDE refractory to conventional medication therapy. However, further studies are needed to confirm this hypothesis.
- Fixed drug eruption; Autoimmunity; Photobiomodulation therapy
How to Cite
References
2. Patel S, John AM, Handler MZ, Schwartz RA. Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption. Am J Clin Dermatol. 2020;21(3):393-399. doi:10.1007/s40257-020-00505-3
3. Shiohara T, Mizukawa Y. Fixed Drug Eruption: The Dark Side of Activation of Intraepidermal CD8+ T Cells Uniquely Specialized to Mediate Protective Immunity. Chem Immunol Allergy. 2012;97:106-121. doi:10.1159/000335623
4. Jhaj R, Chaudhary D, Asati D, Sadasivam B. Fixed-drug eruptions: What can we learn from a case series? Indian J Dermatol. 2018;63(4):332. doi:10.4103/ijd.IJD_481_17
5. Shaker G, Mehendale T, De La Rosa C. Fixed Drug Eruption: An Underrecognized Cutaneous Manifestation of a Drug Reaction in the Primary Care Setting. Cureus. 2022;14(8):e28299. doi:10.7759/cureus.28299
6. Anderson HJ, Lee JB. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption. Medicina (B Aires). 2021;57(9):925. doi:10.3390/medicina57090925
7. Srivastava R, Bhuvan J, Bihari M, Saad A. Fixed drug eruptions with intraoral presentation. Indian J Dent. 2015;6(2):103. doi:10.4103/0975-962X.154376
8. Louzeiro GC, Cherubini K, de Figueiredo MAZ, Salum FG. Effect of photobiomodulation on salivary flow and composition, xerostomia and quality of life of patients during head and neck radiotherapy in short term follow-up: A randomized controlled clinical trial. J Photochem Photobiol B Biol. 2020;209:111933. doi:10.1016/j.jphotobiol.2020.111933
9. Berlingieri G, Alvares CMA, Serrano RV, Palma LF, Campos L. Phototherapies for COVID-19-associated opportunistic oral infections. Photodiagnosis Photodyn Ther. 2022;37:102678. doi:10.1016/j.pdpdt.2021.102678
10. Wickenheisser VA, Zywot EM, Rabjohns EM, Lee HH, Lawrence DS, Tarrant TK. Laser Light Therapy in Inflammatory, Musculoskeletal, and Autoimmune Disease. Curr Allergy Asthma Rep. 2019;19(8):37. doi:10.1007/s11882-019-0869-z
11. Peter JG, Lehloenya R, Dlamini S, et al. Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. J Allergy Clin Immunol Pract. 2017;5(3):547-563. doi:10.1016/j.jaip.2017.01.025
12. Raffaele RM, Baldo ME, Santana GU, Siqueira JM, Palma LF, Campos L. Phototherapies for erythema multiforme secondary to viral infections: A case report of a child. Photodiagnosis Photodyn Ther. 2022;40:103094. doi:10.1016/j.pdpdt.2022.103094
13. Rezende SB, Campos L, Palma LF, et al. Antimicrobial photodynamic therapy for recurrent herpes labialis in chronic graft‐versus‐host disease: A case report. Photodermatol Photoimmunol Photomed. 2021;00:1-3. doi:10.1111/phpp.12655
14. Sampayo-Cordero M, Miguel-Huguet B, Malfettone A, et al. The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II). Int J Environ Res Public Health. 2020;17(18). doi:10.3390/ijerph17186590
- Abstract Viewed: 357 times
- PDF Downloaded: 472 times